CONMED Q3 2025 presentation slides: revenue growth solid as adjusted EPS beats estimates
PositiveFinancial Markets

CONMED Q3 2025 presentation slides: revenue growth solid as adjusted EPS beats estimates
CONMED's Q3 2025 presentation reveals solid revenue growth and an adjusted EPS that surpasses estimates, highlighting the company's strong performance in the medical technology sector. This positive financial news not only boosts investor confidence but also underscores CONMED's effective strategies in navigating market challenges.
— via World Pulse Now AI Editorial System




